fosaprepitant
Generic: fosaprepitant
Labeler: fresenius kabi usa, llcDrug Facts
Product Profile
Brand Name
fosaprepitant
Generic Name
fosaprepitant
Labeler
fresenius kabi usa, llc
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
Active Ingredients
fosaprepitant dimeglumine 150 mg/5mL
Manufacturer
Identifiers & Regulatory
Product NDC
63323-972
Product ID
63323-972_864bb02f-d50d-4ae2-ad9c-82bb1e9aed2c
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA206197
Listing Expiration
2026-12-31
Marketing Start
2019-09-05
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
63323972
Hyphenated Format
63323-972
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
fosaprepitant (source: ndc)
Generic Name
fosaprepitant (source: ndc)
Application Number
ANDA206197 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 150 mg/5mL
Packaging
- 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-972-10) / 10 mL in 1 VIAL, SINGLE-DOSE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "864bb02f-d50d-4ae2-ad9c-82bb1e9aed2c", "openfda": {"upc": ["0363323972103"], "unii": ["D35FM8T64X"], "rxcui": ["1731077"], "spl_set_id": ["ffee61d1-c1c6-4224-871c-ab7ff6cd01e5"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (63323-972-10) / 10 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "63323-972-10", "marketing_start_date": "20190905"}], "brand_name": "Fosaprepitant", "product_id": "63323-972_864bb02f-d50d-4ae2-ad9c-82bb1e9aed2c", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Neurokinin 1 Antagonists [MoA]", "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "product_ndc": "63323-972", "generic_name": "FOSAPREPITANT", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fosaprepitant", "active_ingredients": [{"name": "FOSAPREPITANT DIMEGLUMINE", "strength": "150 mg/5mL"}], "application_number": "ANDA206197", "marketing_category": "ANDA", "marketing_start_date": "20190905", "listing_expiration_date": "20261231"}